Global Radiopharmaceuticals Market Size, Share, Trends, Growth, Report and Forecast 2024-2030

Global Radiopharmaceuticals Market Size, Share, Trends, Growth, Report and Forecast 2024-2030

May 21, 2024
0 Comments

MarkNtel Advisors recently published a report, titled, ” Global Radiopharmaceuticals Market Radiopharmaceuticals Market – By Radioisotope (Technetium 99, Fluorine 18, Iodine 131, Gallium 68, Iodine 123, Others), By Indication (Oncology, Cardiology, Gastroenterology, Nephrology, Others), By Type (Diagnostic, Therapeutic), By End User (Hospitals, Medical Imaging Centers) and Others,. As per as the report The Global Radiopharmaceuticals Market is estimated to grow at a CAGR of around 10.02% during the forecast period, i.e., 2024-30.

Download Sample Copy: https://www.marknteladvisors.com/query/request-sample/radiopharmaceuticals-market.html

Global Radiopharmaceuticals Market Driver:

Increasing Prevalence of Chronic Diseases – There are a large number of patients with cardiovascular diseases globally due to factors, such as changing lifestyles, obesity, an aging population, improved survival rates from heart attacks and strokes, etc. For instance, the British Heart Foundation stated in 2024 that, around 620 million, which makes 1 in 13 people, are living with heart and circulatory diseases across the world.

With that, the adoption of radiopharmaceuticals to perform diagnosis and risk assessment and to monitor the influence of therapies on heart conditions is witnessing growth, propelling the overall Radiopharmaceuticals Market. Also, the prevalence of cancer is increasing across the globe and this is expected to drive the demand for radiopharmaceuticals.

Leading Companies in Global Radiopharmaceuticals Market:

Bayer AG, Iso-Tex Diagnostics, Inc., Jubilant Pharmova Limited, Novartis AG, General Electric Company, Lantheus Holdings, Inc., Eli Lilly and Company, Siemens Healthineers AG, Curium Pharma, Cardinal Health, Blue Earth Diagnostics, Inc. (Bracco Group), Acrotech Biopharma, Northstar Medical Technologies LLC, IBA Radiopharma Solutions, Sun Pharmaceutical Industries, Inc.

Global Radiopharmaceuticals Market Segmentation:

By Radioisotope

-Technetium 99- Market Size & Forecast 2019-2030, USD Million

-Fluorine 18- Market Size & Forecast 2019-2030, USD Million

-Iodine 131- Market Size & Forecast 2019-2030, USD Million

-Gallium 68- Market Size & Forecast 2019-2030, USD Million

-Iodine 123- Market Size & Forecast 2019-2030, USD Million

-Others (Yttrium 90, Indium 111, etc.)- Market Size & Forecast 2019-2030, USD Million

By Indication

-Oncology- Market Size & Forecast 2019-2030, USD Million

-Cardiology- Market Size & Forecast 2019-2030, USD Million

-Gastroenterology- Market Size & Forecast 2019-2030, USD Million

-Nephrology- Market Size & Forecast 2019-2030, USD Million

-Others (Neuroendocrinology, Neurology, etc.)- Market Size & Forecast 2019-2030, USD Million

By Type

-Diagnostic- Market Size & Forecast 2019-2030, USD Million

-Therapeutic- Market Size & Forecast 2019-2030, USD Million

By End User

-Hospitals- Market Size & Forecast 2019-2030, USD Million

-Medical Imaging Centers- Market Size & Forecast 2019-2030, USD Million

-Others (Specialty Clinics, Research Organizations, etc.)- Market Size & Forecast 2019-2030, USD Million

Get Full Access Of Global Radiopharmaceuticals Market Report : https://www.marknteladvisors.com/research-library/radiopharmaceuticals-market.html

By Region

-North America

-South America

-Europe

-The Middle East & Africa

-Asia-Pacific.

Key questions answered in the Global Radiopharmaceuticals Market are:

•What is Global Radiopharmaceuticals Market?

•What was the market size in 2023?

•What is the growth rate of the Global Radiopharmaceuticals Market?

•Which are the factors expected to drive the market growth?

•What are the different segments of the Global Radiopharmaceuticals Market?

•What segments are covered in the Market?

•Who are the key players in the Global Radiopharmaceuticals Market?

About Us

MarkNtel Advisors is a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Reach us:

Call: +1 628 895 8081, +91 120 4278433

Email: sales@marknteladvisors.com  

Visit to know more:  www.marknteladvisors.com

Add a comment

Your email address will not be published. Required fields are marked *

益生菌對人體的益處

Boo
December 25, 2024
吃不下、排不出、消化不好……都會被安利一波 “益生菌”,似乎 “益生菌” 治百病似的,而且不僅給孩子吃,大人們自己也是頻頻種草。 拉肚子了怎麽辦?——吃益生菌! 便秘了怎麽辦?——吃益生菌! 消化不良怎麽辦?——吃益生菌! 腸脹氣怎麽辦?——吃益生菌! 不愛吃飯怎麽辦?——吃益生菌! 那麽更深層次的疑問也就隨之而來:益生菌,真有這麽神嗎?日本表飛鳴益生菌,是越多越好嗎?益生菌,真的無所不能嗎?喝下去的益生菌一定會起作用嗎?河北農業大學食品科技學院高潔將爲你一一解開迷惑。 益生菌到底是什麽? 益生菌的英文名叫 Probiotic,來源于希臘語,本意是 “對生命有益”,所以顧名思義,益生菌就是對生命有益的菌,是一種通過改善人體微生物平衡從而對宿主施加有益影響的微生物,主要是細菌。 我們正常人體內,以腸道爲主,存在大量的共生菌群,超過1000萬億個,益生菌這類細菌不但不是致病菌,反而能通過改善腸道微生物的平衡,産生不可替代的生理作用。 爲了讓大家吃得放心,我國設計了一個嚴格的評審系統來給它們做身份認證,通過了的才是有名分、能作爲商品流通的益生菌。它們分別是兩岐雙岐杆菌、嬰兒雙岐杆菌、長雙岐杆菌、短雙岐杆菌、青春雙岐杆菌、德氏乳杆菌保加利亞種、嗜酸乳杆菌、幹酪乳杆菌幹酪亞種、嗜熱鏈球菌、羅伊氏乳杆菌。另外還有一組比較特殊的,叫 “可用于嬰幼兒食品的菌種”,包括嗜酸乳杆菌、動物雙歧杆菌、乳雙歧杆菌、鼠李糖乳杆菌,也屬于有名分的益生菌。 平時醫院、藥店裏所購買的一般都是益生菌制劑,益生菌制劑和益生菌不同,益生菌制劑是一種由益生菌加工而成的産品,它除了含有益生菌成分外,可能還含有食用香精、乙醇、甜菊素、麥芽糊精等等一些添加劑成分,雖然這些添加劑經國家安全認證,但不表示此類制劑可以長期服用。...
QAS Autos is a multi service company that was established in 2019 in New York. We provide the inventory, parts and service under one roof. We also provide shipping, container loading, half and full cut of vehicles.
Copyright © 2021. All rights reserved.